Condition: Neoplasms, Colorectal · Sponsor: José Carlos Marín Gabriel
EMR and ESD are both effective and safe and are associated with a very low risk of procedure related mortality when performed for colorectal laterally spreading lesions (LSL). Some kind of LSLs have a low risk of submucosal invasive carcinoma (SMIC) or these foci are found in well demarcated areas of the tumor. This is the case of the non-granular flat elevated (LSN-NG-FE) and the LSLs-G mixed subtypes. The investigators aim to assess if piecemeal EMR (the older technique) for LSLs-G mixed type \> 30 mm and LSLs-NG FE type \> 20 mm is not inferior to ESD (the new treatment) for the need of additional surgery in the mid-term.
This description comes directly from the study's public registry record.
José C. Marín-Gabriel, Assoc. Prof. · +34 91 779 28 27 · josecarlos.marin@salud.madrid.org
Esperanza Ulloa-Márquez · +34 91 779 28 27 · esperanza.ulloa@salud.madrid.org
Always discuss trial participation with your own doctor first.
| Hospital Universitario "12 de Octubre" | Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04593407